[go: up one dir, main page]

PL3305291T3 - Zastosowania pochodnej benzimidazolu w nocnym przełomie wydzielania kwasu - Google Patents

Zastosowania pochodnej benzimidazolu w nocnym przełomie wydzielania kwasu

Info

Publication number
PL3305291T3
PL3305291T3 PL16807788T PL16807788T PL3305291T3 PL 3305291 T3 PL3305291 T3 PL 3305291T3 PL 16807788 T PL16807788 T PL 16807788T PL 16807788 T PL16807788 T PL 16807788T PL 3305291 T3 PL3305291 T3 PL 3305291T3
Authority
PL
Poland
Prior art keywords
benzimidazole derivative
acid breakthrough
nocturnal acid
nocturnal
breakthrough
Prior art date
Application number
PL16807788T
Other languages
English (en)
Inventor
Ha Jin Lee
Bong Tae Kim
Hyun Kim
Ji Yeon NAM
Jie Eun Park
Geun Seog Song
Shin Young Ryu
Shinichi Koizumi
Nobuyuki Takahashi
Masaomi Tajimi
Original Assignee
Hk Inno.N Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57504150&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3305291(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hk Inno.N Corporation filed Critical Hk Inno.N Corporation
Publication of PL3305291T3 publication Critical patent/PL3305291T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL16807788T 2015-06-08 2016-06-08 Zastosowania pochodnej benzimidazolu w nocnym przełomie wydzielania kwasu PL3305291T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562172680P 2015-06-08 2015-06-08
EP16807788.1A EP3305291B1 (en) 2015-06-08 2016-06-08 Uses of benzimidazole derivative for nocturnal acid breakthrough
PCT/KR2016/006072 WO2016200148A1 (ko) 2015-06-08 2016-06-08 야간 산 분비에 대한 벤즈이미다졸 유도체의 용도

Publications (1)

Publication Number Publication Date
PL3305291T3 true PL3305291T3 (pl) 2021-11-02

Family

ID=57504150

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16807788T PL3305291T3 (pl) 2015-06-08 2016-06-08 Zastosowania pochodnej benzimidazolu w nocnym przełomie wydzielania kwasu

Country Status (27)

Country Link
US (2) US10512635B2 (pl)
EP (1) EP3305291B1 (pl)
JP (1) JP6792269B2 (pl)
KR (3) KR20160144927A (pl)
CN (2) CN108012527A (pl)
CL (1) CL2017003133A1 (pl)
CY (1) CY1124590T1 (pl)
DK (1) DK3305291T3 (pl)
ES (1) ES2890481T3 (pl)
HK (1) HK1252562A1 (pl)
HR (1) HRP20211046T1 (pl)
HU (1) HUE056322T2 (pl)
IL (1) IL256127B (pl)
LT (1) LT3305291T (pl)
MA (1) MA41730B1 (pl)
MX (1) MX374972B (pl)
MY (1) MY197209A (pl)
PH (1) PH12017502221A1 (pl)
PL (1) PL3305291T3 (pl)
PT (1) PT3305291T (pl)
RS (1) RS62074B1 (pl)
RU (1) RU2672248C1 (pl)
SG (1) SG11201710006PA (pl)
SI (1) SI3305291T1 (pl)
SM (1) SMT202100399T1 (pl)
TN (1) TN2017000510A1 (pl)
WO (1) WO2016200148A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101960357B1 (ko) * 2016-12-26 2019-03-20 씨제이헬스케어 주식회사 벤즈이미다졸 유도체를 포함하는 신규한 제제
KR102262743B1 (ko) * 2017-07-07 2021-06-09 에이치케이이노엔 주식회사 주사용 조성물
JOP20190201A1 (ar) * 2018-08-29 2020-02-29 Hk Inno N Corp تركيبة لاستئصال الملوية البوابية
EP3927340B1 (en) * 2019-02-18 2025-09-03 HK inno.N Corporation Pharmaceutical composition comprising tegoprazan for preventing the recurrence of gastroesophageal reflux disease
UY39094A (es) * 2020-02-27 2021-07-30 Hk Inno N Corp Composición farmacéutica que comprende compuesto derivado de bencimidazol
US20220020481A1 (en) 2020-07-20 2022-01-20 Abbott Laboratories Digital pass verification systems and methods
CA3196459A1 (en) * 2020-10-23 2022-04-28 Min Jung Kim Orally disintegrating tablet comprising benzimidazole derivative compound and preparation method thereof
KR102648315B1 (ko) * 2021-12-08 2024-03-15 (주) 팜젠사이언스 벤즈이미다졸 유도체 화합물 및 이의 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR043063A1 (es) * 2002-12-13 2005-07-13 Altana Pharma Ag Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas
MXPA06002443A (es) * 2003-09-03 2006-08-31 Agi Therapeutics Ltd Formulaciones inhibidoras de la bomba de protones y metodos para preparar y utilizar tales formulaciones.
WO2006134460A1 (en) 2005-06-14 2006-12-21 Pfizer Japan Inc. Chromane substituted benzimidazole derivatives as acid pump antagonists
BR122020004679B1 (pt) * 2005-12-19 2021-09-21 Raqualia Pharma Inc Composição farmacêutica
WO2008067037A2 (en) 2006-10-05 2008-06-05 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
WO2008151927A2 (en) * 2007-06-15 2008-12-18 Nycomed Gmbh 6-n-substituted benz imidazole derivatives as acid pump antagonists
NZ588379A (en) 2008-03-10 2012-07-27 Takeda Pharmaceutical Crystal of benzimidazole compound
MX2012000275A (es) 2009-07-09 2012-02-08 Raqualia Pharma Inc Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
CN102140099A (zh) 2010-02-02 2011-08-03 山东轩竹医药科技有限公司 新的吡啶衍生物
RU2537140C1 (ru) * 2013-09-17 2014-12-27 Леонид Федосеевич Ляпустин Способ антихеликобактерной терапии желудка и двенадцатиперстной кишки

Also Published As

Publication number Publication date
SG11201710006PA (en) 2018-01-30
KR20180036931A (ko) 2018-04-10
IL256127A (en) 2018-02-28
CL2017003133A1 (es) 2018-04-13
MA41730B1 (fr) 2019-03-29
KR102061052B1 (ko) 2019-12-31
PT3305291T (pt) 2021-07-05
HRP20211046T1 (hr) 2021-10-01
DK3305291T3 (da) 2021-06-28
MX2017015926A (es) 2018-07-06
RS62074B1 (sr) 2021-07-30
KR20200002739A (ko) 2020-01-08
US20180338954A1 (en) 2018-11-29
JP6792269B2 (ja) 2020-11-25
TN2017000510A1 (en) 2019-04-12
RU2672248C1 (ru) 2018-11-13
EP3305291A4 (en) 2019-01-23
HK1252562A1 (zh) 2019-05-31
EP3305291A1 (en) 2018-04-11
PH12017502221A1 (en) 2018-06-04
WO2016200148A1 (ko) 2016-12-15
IL256127B (en) 2021-04-29
EP3305291B1 (en) 2021-05-19
MY197209A (en) 2023-06-01
KR20160144927A (ko) 2016-12-19
MX374972B (es) 2025-03-06
CN108012527A (zh) 2018-05-08
SMT202100399T1 (it) 2021-09-14
US20200069652A1 (en) 2020-03-05
JP2018516951A (ja) 2018-06-28
ES2890481T3 (es) 2022-01-20
US11033532B2 (en) 2021-06-15
SI3305291T1 (sl) 2021-08-31
MA41730A1 (fr) 2018-08-31
US10512635B2 (en) 2019-12-24
CY1124590T1 (el) 2022-07-22
LT3305291T (lt) 2021-08-25
HUE056322T2 (hu) 2022-02-28
CN118557572A (zh) 2024-08-30

Similar Documents

Publication Publication Date Title
IL287517A (en) Benzimidazole compounds as c-kit inhibitors
IL254318B (en) History of benzaimidazoles as bromodomain inhibitors
SG11201706729SA (en) Derivatives of sobetirome
SMT202100399T1 (it) Utilizzo dei derivati del benzimidazolo episodi acidi notturni
HUE040612T2 (hu) Pirazolkarbonsav-alkoxiamidok fungicid hatású készítményei
PL3107391T3 (pl) Grzybobójcze kompozycje alkoksyamidów kwasów pirazolokarboksylowych
SG11201701378WA (en) Pyrido-oxazinone derivatives as tnap inhibitors
IL241096B (en) Treatment methods
IL258520B (en) A method for the preparation of 2-mercaptobenzothiazole
HUE068403T2 (hu) Új eljárás állatgyógyászati szerek helyi alkalmazására
GB201323123D0 (en) Method for the preparation of biopolymers
PL2997014T3 (pl) Sposób wytwarzania pochodnych kwasu 6-trifluorometylopirydyno-3-karboksylowego z kwasu trifluoroacetylooctowego
TWM490377U (en) Improved structure of C clamp
SMT201900705T1 (it) Procedimenti per preparare derivati di indazolo
TH1401006701A (th) วิธีการสำหรับการเตรียมของสารประกอบไตรอาซอล
TWM489076U (en) Improved structure of protective paster
GB201306411D0 (en) Treatment of inflammatory conditions
GB201322778D0 (en) Method of treatment
GB201314882D0 (en) Method of treatment